Nello Mainolfi

Nello Mainolfi

Company: Kymera Therapeutics

Job title: Founder, President & Chief Executive Officer


Targeted Protein Degradation Beyond Oncology 9:00 am

Advancing understanding and impact of TPD beyond existing E3 ligases What is needed to build programs beyond oncology IRAK4 degrader programs in immunologyRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.